Globus Medical Launches INDEPENDENCE MIS™, a Minimally Invasive ALIF Integrated Plate-Spacer
October 25 2016 - 4:15PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant
manufacturer, today announced the introduction of the INDEPENDENCE
MIS™ System, an integrated ALIF plate-spacer system designed to
simplify implantation and fixation of a commonly challenging
procedure.
The INDEPENDENCE MIS™ system features advanced instruments that
deploy three pre-loaded anchors through a small protected corridor
no larger than the implant itself. Most integrated ALIF
systems either use screws, which tend to require a much larger
access to insert due to their orientation, or wide blades impacted
into the bone that can be hard to retrieve. INDEPENDENCE MIS™
streamlines the anterior procedure into three simple steps:
inserting the implant, deploying the anchors, and locking the
anchors.
“This device is a game-changer,” commented Andrew Iott, Senior
Vice President of Product Development. “It builds on the
philosophy and success of the INDEPENDENCE® system by delivering a
swift, streamlined procedure that enables surgeons to perform an
ALIF in fewer steps while preserving the versatility to use
screws. INDEPENDENCE MIS™ is another proud addition to our
innovative suite of MIS products.”
Indications
INDEPENDENCE® (including INDEPENDENCE MIS™, INDEPENDENCE® TPS,
and INDEPENDENCE MIS™ TPS) Spacers are interbody fusion devices
intended for use in patients with degenerative disc disease (DDD)
at one or two contiguous levels of the lumbosacral spine (L2-S1).
DDD is defined as discogenic back pain with degeneration of the
disc confirmed by history and radiographic studies. These patients
should be skeletally mature and have had at least six (6) months of
non-operative treatment. In addition, these patients may have up to
Grade 1 spondylolisthesis or retrolisthesis at the involved
level(s). INDEPENDENCE® Spacers are to be filled with autograft
bone and/or allogenic bone graft composed of cancellous and/or
corticocancellous bone.
The INDEPENDENCE® Spacer is a stand-alone interbody fusion
device intended to be used with three titanium alloy screws which
accompany the implant. The INDEPENDENCE MIS™ Spacer is an
interbody fusion device to be used with three titanium alloy screws
or anchors which accompany the implants. When used with screws, the
INDEPENDENCE MIS™ Spacer is a stand-alone interbody fusion
device. When used with anchors, the INDEPENDENCE MIS™ Spacer is
intended for use with supplemental fixation (e.g. facet screws or
posterior fixation). Hyperlordotic implants (≥25° lordosis) are
intended for use with supplemental fixation (e.g. facet screws or
posterior fixation).
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal implant
company based in Audubon, PA. The company was founded in 2003 by an
experienced team of professionals with a shared vision to create
products that enable surgeons to promote healing in patients with
musculoskeletal disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than
statements of historical fact are forward-looking statements and
may be identified by their use of words such as “believe,” “may,”
“might,” “could,” “will,” “aim,” “estimate,” “continue,”
“anticipate,” “intend,” “expect,” “plan” and other similar terms.
These forward-looking statements are based on our current
assumptions, expectations and estimates of future events and
trends. Forward-looking statements are only predictions and are
subject to many risks, uncertainties and other factors that may
affect our businesses and operations and could cause actual results
to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
comply with changing laws and regulations that are applicable to
our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us,
trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:
Dan Scavilla
Senior Vice President and Chief Financial Officer
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Sep 2023 to Sep 2024